FILTER

FILTERED INTERVIEW RESULTS

Patricio Massera

CEO, AGC BIOLOGICS
AGC Biologic’s explains its expansion in the US.

Olga Potapova

FOUNDER, CEO & SCIENTIFIC DIRECTOR, CURELINE
Cureline updates GBR on its global activities.

Jennifer Cannon

SVP GLOBAL HEAD OF MAMMALIAN BIOLOGICS, LONZA
"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."

Mark Egerton

CEO, QUOTIENT SCIENCES
"The focus of our integrated Translational Pharmaceutics programs is to provide the customer with a development platform capable of responding in real-time to emerging development data and maintain an overall timeline to proof of concept."

Peter DeYoung

CEO, PIRAMAL PHARMA SOLUTIONS
Piramal Pharma Solutions comments on its continued global expansion.

Manni Kantipudi & Ramesh Subramanian

CHIEF EXECUTIVE OFFICER (CEO) AND CHIEF COMMERCIAL OFFICER (CCO), ARAGEN LIFE SCIENCES
Aragen Life Sciences explains how its expansion in both India and US can benefit drug discovery companies.

Robert Bloder

CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
"We were excited to secure equity investment from Signet Healthcare Partners and have since almost doubled in size in both our capacity and talent pool."

Will Lewis

CHAIRMAN & CEO, INSMED
"Insmed developed a drug-device combination that became the first approved therapy to treat patients with a refractory form of a rare and serious lung infection."

Anne Pritchett

SENIOR VICE PRESIDENT OF POLICY, RESEARCH AND MEMBERSHIP, PHRMA
"Our organization advocates for public policies that encourage the research and development and manufacturing of new medicines that allow patients to lead longer, healthier, and more productive lives."

Tom Sellig

CEO, ADARE PHARMA SOLUTIONS
"Our reputation is based on how we deploy technologies to solve complex formulation challenges."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mongolia Mining 2024 - Digital Interactive

Investors once came to Mongolia for its geology yet stumbled upon its legislative framework. How competitive Mongolia has become today, we will leave our readers to judge, hoping that this report provides them with the resources to make an informed assessment.

PARTNER EVENTS